Ionis Pharmaceuticals (IONS) PT Lowered to $55 at Morgan Stanley
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $58.63 +2.43%
Rating Summary:
18 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
18 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Morgan Stanley analyst Michael Ulz lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $55.00 (from $60.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Ashok Leyland Ltd. (AL:IN) PT Raised to INR194 at Nomura/Instinet
- Maxis Bhd (MAXIS:MK) (MAXSF) PT Raised to MYR3.82 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
